Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer (Q80287572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Santiago Ramon y Cajal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Angel Garcia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Federico Rojo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Carmen Ruiz-Marcellan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Antonio Gil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jose Baselga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1801-1811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

A census of human cancer genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Integration of growth factor and nutrient signaling: implications for cancer biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Signaling control of mRNA translation in cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Does the ribosome translate cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

mTOR, translational control and human disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

PI 3-kinase, mTOR, protein synthesis and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Diverse tumorigenic pathways in ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Regulation of translation initiation by FRAP/mTOR

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

The TOR pathway: a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Initiation of mRNA translation in oncogenesis: the role of eIF4E.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

eIF-4E expression and its role in malignancies and metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Regulation of cap-dependent translation by eIF4E inhibitory proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22195

7 January 2021

Identifiers

DOI

10.1002/CNCR.22195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983702%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference